Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Predicting Hemolytic Uremic Syndrome and Renal Failure in Shiga Toxin-Producing Escherichia coli Infected Children.

McKee RS, Schnadower D, Tarr PI, Xie J, Finkelstein Y, Desai N, Lane RD, Bergmann KR, Kaplan RL, Hariharan S, Cruz AT, Cohen DM, Dixon A, Ramgopal S, Rominger A, Powell EC, Kilgar J, Michelson KA, Beer D, Bitzan M, Pruitt CM, Yen K, Meckler GD, Plint AC, Bradin S, Abramo TJ, Gouin S, Kam AJ, Schuh A, Balamuth F, Hunley TE, Kanegaye JT, Jones NE, Avva U, Porter R, Fein DM, Louie JP, Freedman SB; Pediatric Emergency Medicine Collaborative Research Committee (PEMCRC); Pediatric Emergency Research Canada (PERC).

Clin Infect Dis. 2019 May 24. pii: ciz432. doi: 10.1093/cid/ciz432. [Epub ahead of print]

PMID:
31125419
2.

Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis.

Chung CF, Kitzler T, Kachurina N, Pessina K, Babayeva S, Bitzan M, Kaskel F, Colmegna I, Alachkar N, Goodyer P, Cybulsky AV, Torban E.

PLoS One. 2019 May 16;14(5):e0216426. doi: 10.1371/journal.pone.0216426. eCollection 2019.

3.

The Canadian childhood nephrotic syndrome (CHILDNEPH) study: report on mid-study feasibility, recruitment and main measures.

Samuel SM, Dart A, Filler G, Bitzan M, Pinsk M, Mammen C, Nettel-Aguirre A, Perinpanayagam MA, Takano T, Chanchlani R, Zappitelli M; other members of the Canadian Childhood Nephrotic Syndrome Project Team.

BMC Nephrol. 2019 May 14;20(1):159. doi: 10.1186/s12882-019-1320-3.

4.

Theophylline and aminophylline for prevention of acute kidney injury in neonates and children: a systematic review.

Bhatt GC, Gogia P, Bitzan M, Das RR.

Arch Dis Child. 2019 Jul;104(7):670-679. doi: 10.1136/archdischild-2018-315805. Epub 2019 Feb 23.

PMID:
30798259
5.

Hypophosphatemic Rickets.

Bitzan M, Goodyer PR.

Pediatr Clin North Am. 2019 Feb;66(1):179-207. doi: 10.1016/j.pcl.2018.09.004. Review.

PMID:
30454743
6.

Renal Tubular Acidosis.

Alexander RT, Bitzan M.

Pediatr Clin North Am. 2019 Feb;66(1):135-157. doi: 10.1016/j.pcl.2018.08.011. Review.

PMID:
30454739
7.

Complement depletion and Coombs positivity in pneumococcal hemolytic uremic syndrome (pnHUS). Case series and plea to revisit an old pathogenetic concept.

Bitzan M, AlKandari O, Whittemore B, Yin XL.

Int J Med Microbiol. 2018 Dec;308(8):1096-1104. doi: 10.1016/j.ijmm.2018.08.007. Epub 2018 Aug 29.

8.

Renal tubular dysgenesis and microcolon, a novel association. Report of three cases.

Saskin A, Alfares A, Bernard C, Blumenkrantz M, Braverman N, Gupta I, Brosnihan KB, Antignac C, Gubler MC, Morinière V, De Bie I, Bitzan M.

Eur J Med Genet. 2019 Apr;62(4):254-258. doi: 10.1016/j.ejmg.2018.07.024. Epub 2018 Jul 31.

PMID:
30071301
9.

Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome.

Kitzler TM, Kachurina N, Bitzan MM, Torban E, Goodyer PR.

Pediatr Nephrol. 2018 Oct;33(10):1741-1750. doi: 10.1007/s00467-018-3995-2. Epub 2018 Jul 7.

PMID:
29982877
10.

Acquired thrombotic thrombocytopenic purpura with isolated CFHR3/1 deletion-rapid remission following complement blockade.

Bitzan M, Hammad RM, Bonnefoy A, Al Dhaheri WS, Vézina C, Rivard GÉ.

Pediatr Nephrol. 2018 Aug;33(8):1437-1442. doi: 10.1007/s00467-018-3957-8. Epub 2018 May 4.

11.

Influenza-associated thrombotic microangiopathies.

Bitzan M, Zieg J.

Pediatr Nephrol. 2018 Nov;33(11):2009-2025. doi: 10.1007/s00467-017-3783-4. Epub 2017 Sep 7. Review.

12.

Rituximab in Minimal Change Disease: Mechanisms of Action and Hypotheses for Future Studies.

Madanchi N, Bitzan M, Takano T.

Can J Kidney Health Dis. 2017 Mar 13;4:2054358117698667. doi: 10.1177/2054358117698667. eCollection 2017. Review.

13.

Setting New Directions for Research in Childhood Nephrotic Syndrome: Results From a National Workshop.

Samuel SM, Takano T, Scott S, Benoit G, Bitzan M, Mammen C, Ryan L, Morgan C; Canadian Childhood Nephrotic Syndrome Project Team.

Can J Kidney Health Dis. 2017 Apr 24;4:2054358117703386. doi: 10.1177/2054358117703386. eCollection 2017.

14.

Novel unbiased assay for circulating podocyte-toxic factors associated with recurrent focal segmental glomerulosclerosis.

Kachurina N, Chung CF, Benderoff E, Babayeva S, Bitzan M, Goodyer P, Kitzler T, Matar D, Cybulsky AV, Alachkar N, Torban E.

Am J Physiol Renal Physiol. 2016 May 15;310(10):F1148-56. doi: 10.1152/ajprenal.00349.2015. Epub 2015 Dec 30.

15.

An international consensus approach to the management of atypical hemolytic uremic syndrome in children.

Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, Coppo R, Emma F, Johnson S, Karpman D, Landau D, Langman CB, Lapeyraque AL, Licht C, Nester C, Pecoraro C, Riedl M, van de Kar NC, Van de Walle J, Vivarelli M, Frémeaux-Bacchi V; HUS International.

Pediatr Nephrol. 2016 Jan;31(1):15-39. doi: 10.1007/s00467-015-3076-8. Epub 2015 Apr 11. Review.

PMID:
25859752
16.

An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome.

Johnson S, Stojanovic J, Ariceta G, Bitzan M, Besbas N, Frieling M, Karpman D, Landau D, Langman C, Licht C, Pecoraro C, Riedl M, Siomou E, van de Kar N, Walle JV, Loirat C, Taylor CM.

Pediatr Nephrol. 2014 Oct;29(10):1967-78. doi: 10.1007/s00467-014-2817-4. Epub 2014 May 11.

PMID:
24817340
17.

Canadian Society of Nephrology Commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis: management of nephrotic syndrome in children.

Samuel S, Bitzan M, Zappitelli M, Dart A, Mammen C, Pinsk M, Cybulsky AV, Walsh M, Knoll G, Hladunewich M, Bargman J, Reich H, Humar A, Muirhead N.

Am J Kidney Dis. 2014 Mar;63(3):354-62. doi: 10.1053/j.ajkd.2013.12.002. Epub 2014 Jan 11. Review.

PMID:
24423782
18.

Canadian Society of Nephrology Commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis: management of glomerulonephritis in adults.

Cybulsky AV, Walsh M, Knoll G, Hladunewich M, Bargman J, Reich H, Humar A, Samuel S, Bitzan M, Zappitelli M, Dart A, Mammen C, Pinsk M, Muirhead N.

Am J Kidney Dis. 2014 Mar;63(3):363-77. doi: 10.1053/j.ajkd.2013.12.001. Epub 2014 Jan 11. Review.

PMID:
24423780
19.

The Canadian Childhood Nephrotic Syndrome (CHILDNEPH) Project: overview of design and methods.

Samuel S, Scott S, Morgan C, Dart A, Mammen C, Parekh R, Nettel-Aguirre A, Eddy A, Flynn R, Pinsk M, Wade A, Arora S, Benoit G, Bitzan M, Erickson R, Feber J, Filler G, Geier P, Girardin C, Grisaru S, Tee J, Kemp K, Zappitelli M.

Can J Kidney Health Dis. 2014 Jul 22;1:17. doi: 10.1186/2054-3581-1-17. eCollection 2014.

20.

Cyclosporine/ketoconazole reduces treatment costs for nephrotic syndrome.

Iyengar A, Kamath N, Phadke KD, Bitzan M.

Indian J Nephrol. 2013 Nov;23(6):419-23. doi: 10.4103/0971-4065.120338.

21.

Substantial practice variation exists in the management of childhood nephrotic syndrome.

Samuel S, Morgan CJ, Bitzan M, Mammen C, Dart AB, Manns BJ, Alexander RT, Erickson RL, Grisaru S, Wade AW, Blydt-Hansen T, Feber J, Arora S, Licht C, Zappitelli M.

Pediatr Nephrol. 2013 Dec;28(12):2289-98. doi: 10.1007/s00467-013-2546-0. Epub 2013 Aug 6.

PMID:
23917450
22.

Erratum to "endolymphatic sac enlargement in a girl with a novel mutation for distal renal tubular acidosis and severe deafness".

Rink N, Bitzan M, O'Gorman G, Nagel M, Torban E, Goodyer P.

Case Rep Pediatr. 2013;2013:356031. doi: 10.1155/2013/356031. Epub 2013 Apr 4. No abstract available.

23.

ARHGDIA: a novel gene implicated in nephrotic syndrome.

Gupta IR, Baldwin C, Auguste D, Ha KC, El Andalousi J, Fahiminiya S, Bitzan M, Bernard C, Akbari MR, Narod SA, Rosenblatt DS, Majewski J, Takano T.

J Med Genet. 2013 May;50(5):330-8. doi: 10.1136/jmedgenet-2012-101442. Epub 2013 Feb 22.

24.

TNFα pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and β3 integrin activation.

Bitzan M, Babayeva S, Vasudevan A, Goodyer P, Torban E.

Pediatr Nephrol. 2012 Dec;27(12):2217-26. doi: 10.1007/s00467-012-2163-3. Epub 2012 Apr 27.

PMID:
22538781
25.

Native nephrectomy prior to pediatric kidney transplantation: biological and clinical aspects.

Ghane Sharbaf F, Bitzan M, Szymanski KM, Bell LE, Gupta I, Tchervenkov J, Capolicchio JP.

Pediatr Nephrol. 2012 Jul;27(7):1179-88. doi: 10.1007/s00467-012-2115-y. Epub 2012 Feb 26.

26.

Recurrent focal segmental glomerulosclerosis: a discrete clinical entity.

Torban E, Bitzan M, Goodyer P.

Int J Nephrol. 2012;2012:246128. doi: 10.1155/2012/246128. Epub 2012 Jan 11.

27.

Management of hemolytic uremic syndrome.

Loirat C, Saland J, Bitzan M.

Presse Med. 2012 Mar;41(3 Pt 2):e115-35. doi: 10.1016/j.lpm.2011.11.013. Epub 2012 Jan 27.

PMID:
22284541
28.

Spectrum of mutations in the renin-angiotensin system genes in autosomal recessive renal tubular dysgenesis.

Gribouval O, Morinière V, Pawtowski A, Arrondel C, Sallinen SL, Saloranta C, Clericuzio C, Viot G, Tantau J, Blesson S, Cloarec S, Machet MC, Chitayat D, Thauvin C, Laurent N, Sampson JR, Bernstein JA, Clemenson A, Prieur F, Daniel L, Levy-Mozziconacci A, Lachlan K, Alessandri JL, Cartault F, Rivière JP, Picard N, Baumann C, Delezoide AL, Belar Ortega M, Chassaing N, Labrune P, Yu S, Firth H, Wellesley D, Bitzan M, Alfares A, Braverman N, Krogh L, Tolmie J, Gaspar H, Doray B, Majore S, Bonneau D, Triau S, Loirat C, David A, Bartholdi D, Peleg A, Brackman D, Stone R, DeBerardinis R, Corvol P, Michaud A, Antignac C, Gubler MC.

Hum Mutat. 2012 Feb;33(2):316-26. doi: 10.1002/humu.21661. Epub 2011 Dec 22. Review.

PMID:
22095942
29.

Plasma from a case of recurrent idiopathic FSGS perturbs non-muscle myosin IIA (MYH9 protein) in human podocytes.

Babayeva S, Miller M, Zilber Y, El Kares R, Bernard C, Bitzan M, Goodyer P, Torban E.

Pediatr Nephrol. 2011 Jul;26(7):1071-81. doi: 10.1007/s00467-011-1831-z. Epub 2011 Mar 6.

PMID:
21380797
30.

Treatment of typical (enteropathic) hemolytic uremic syndrome.

Bitzan M, Schaefer F, Reymond D.

Semin Thromb Hemost. 2010 Sep;36(6):594-610. doi: 10.1055/s-0030-1262881. Epub 2010 Sep 23. Review.

PMID:
20865636
31.

Is retroperitoneoscopy the gold standard for endoscopic nephrectomy in children on peritoneal dialysis?

Szymanski KM, Bitzan M, Capolicchio JP.

J Urol. 2010 Oct;184(4 Suppl):1631-7. doi: 10.1016/j.juro.2010.04.019. Epub 2010 Aug 21.

PMID:
20728139
32.

Cryptogenic organizing pneumonia after rituximab therapy for presumed post-kidney transplant lymphoproliferative disease.

Bitzan M, Ouahed JD, Carpineta L, Bernard C, Bell LE.

Pediatr Nephrol. 2010 Jun;25(6):1163-7. doi: 10.1007/s00467-010-1447-8. Epub 2010 Feb 6.

PMID:
20140460
33.

Rituximab (B-cell depleting antibody) associated lung injury (RALI): a pediatric case and systematic review of the literature.

Bitzan M, Anselmo M, Carpineta L.

Pediatr Pulmonol. 2009 Sep;44(9):922-34. doi: 10.1002/ppul.20864. Review.

PMID:
19681063
34.

Safety and pharmacokinetics of chimeric anti-Shiga toxin 1 and anti-Shiga toxin 2 monoclonal antibodies in healthy volunteers.

Bitzan M, Poole R, Mehran M, Sicard E, Brockus C, Thuning-Roberson C, Rivière M.

Antimicrob Agents Chemother. 2009 Jul;53(7):3081-7. doi: 10.1128/AAC.01661-08. Epub 2009 May 4.

35.

Treatment options for HUS secondary to Escherichia coli O157:H7.

Bitzan M.

Kidney Int Suppl. 2009 Feb;(112):S62-6. doi: 10.1038/ki.2008.624. Review.

PMID:
19180140
36.

Analysis of genes encoding laminin beta2 and related proteins in patients with Galloway-Mowat syndrome.

Dietrich A, Matejas V, Bitzan M, Hashmi S, Kiraly-Borri C, Lin SP, Mildenberger E, Hoppe B, Palm L, Shiihara T, Steiss JO, Tsai JD, Vester U, Weber S, Wühl E, Zepf K, Zenker M.

Pediatr Nephrol. 2008 Oct;23(10):1779-86. doi: 10.1007/s00467-008-0880-4. Epub 2008 Jul 2.

PMID:
18594871
37.

Rituximab treatment of collapsing C1q glomerulopathy: clinical and histopathological evolution.

Bitzan M, Ouahed JD, Krishnamoorthy P, Bernard C.

Pediatr Nephrol. 2008 Aug;23(8):1355-61. doi: 10.1007/s00467-008-0781-6. Epub 2008 Mar 20.

PMID:
18351394
38.

Sirolimus-associated chronic pyogenic periungual infection.

Raju DL, Bitzan M.

Kidney Int. 2007 Mar;71(6):476. No abstract available.

39.

Adaptation of Shiga toxin-producing Escherichia coli to various reservoirs and the human host.

Bitzan MM.

Berl Munch Tierarztl Wochenschr. 2005 Nov-Dec;118(11-12):437-40. No abstract available.

PMID:
16318266
40.

Peritonitis due to Neisseria mucosa in an adolescent receiving peritoneal dialysis.

Shetty AK, Nagaraj SK, Lorentz WB, Bitzan M.

Infection. 2005 Oct;33(5-6):390-2.

PMID:
16258875
41.
43.

Non-enteropathic hemolytic uremic syndrome: causes and short-term course.

Constantinescu AR, Bitzan M, Weiss LS, Christen E, Kaplan BS, Cnaan A, Trachtman H.

Am J Kidney Dis. 2004 Jun;43(6):976-82.

PMID:
15168377
44.

Serological methods for the detection of STEC infections.

Bitzan M, Karch H.

Methods Mol Med. 2003;73:27-43. Review. No abstract available.

PMID:
12375436
45.

Interaction of Shiga toxin with endothelial cells.

Bitzan M, te Loo DM.

Methods Mol Med. 2003;73:243-62. Review. No abstract available.

PMID:
12375434
46.

Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy.

Hoffmann IM, Rubin BK, Iskandar SS, Schechter MS, Nagaraj SK, Bitzan MM.

Pediatr Pulmonol. 2002 Nov;34(5):375-7.

PMID:
12357482
47.

Escherichia coli O157 fails to induce a long-lasting lipopolysaccharide-specific, measurable humoral immune response in children with hemolytic-uremic syndrome.

Ludwig K, Bitzan M, Bobrowski C, Müller-Wiefel DE.

J Infect Dis. 2002 Aug 15;186(4):566-9. Epub 2002 Aug 2.

PMID:
12195387
48.

Saliva IgM and IgA are a sensitive indicator of the humoral immune response to Escherichia coli O157 lipopolysaccharide in children with enteropathic hemolytic uremic syndrome.

Ludwig K, Grabhorn E, Bitzan M, Bobrowski C, Kemper MJ, Sobottka I, Laufs R, Karch H, Müller-Wiefel DE.

Pediatr Res. 2002 Aug;52(2):307-13.

PMID:
12149511
49.

Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome.

Ludwig K, Sarkim V, Bitzan M, Karmali MA, Bobrowski C, Ruder H, Laufs R, Sobottka I, Petric M, Karch H, Müller-Wiefel DE.

J Clin Microbiol. 2002 May;40(5):1773-82.

50.

Molecular characteristics and epidemiological significance of Shiga toxin-producing Escherichia coli O26 strains.

Zhang WL, Bielaszewska M, Liesegang A, Tschäpe H, Schmidt H, Bitzan M, Karch H.

J Clin Microbiol. 2000 Jun;38(6):2134-40.

Supplemental Content

Loading ...
Support Center